Lubor Gaal serves as Executive at Timber Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Lubor Gaal has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 15, 2023 involved receiving (via award) 4,100 shares valued at $0.
Lubor Gaal currently holds 6,100 shares of Timber Pharmaceuticals, Inc. (TMBR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lubor Gaal has been a net neutral trader of TMBR stock. They have purchased $0 and sold $0 worth of shares.
Lubor Gaal's most recent insider trade was on Apr 15, 2023, when they sold 4,100 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |